Combining sedatives like opioids, benzodiazepines, and alcohol can cause deadly respiratory depression. Learn the risks, common dangerous mixes, and what to do if you're taking multiple CNS depressants.
Combining sedatives like opioids, benzodiazepines, and alcohol can cause deadly respiratory depression. Learn the risks, common dangerous mixes, and what to do if you're taking multiple CNS depressants.
Pancreatic cancer often shows no early symptoms, but signs like new-onset diabetes, unexplained weight loss, and jaundice can be critical clues. Learn about the latest treatments improving survival and what’s on the horizon for early detection.
Weekend weight gain is a common but preventable pattern of calorie creep that undermines long-term weight loss. Learn how small, realistic changes to eating and movement on weekends can stop annual weight gain before it starts.
Warfarin and antibiotics can dangerously interact, raising your risk of bleeding. Learn which antibiotics are high-risk, when to check your INR, and how to stay safe without stopping your blood thinner.
Behind-the-counter medications require pharmacist consultation but no prescription. Learn what drugs are restricted in Australia, why they’re controlled, and how to navigate the process without hassle.
The ANDA process is the legal pathway for generic drug approval in the U.S., governed by the Hatch-Waxman Act. It requires bioequivalence, identical formulation, and strict manufacturing standards to ensure safe, affordable alternatives to brand-name drugs.
FDA safety alerts in 2025 hit record levels, with urgent warnings on tainted supplements, unsafe medical devices, and unapproved compounded drugs. Know what's changing and how to protect yourself.
The FDA's 2023-2025 updates to generic drug approvals prioritize U.S.-made medications to fix supply chain gaps. Learn how the new pilot program affects drug availability, pricing, and manufacturing.
Dependence on foreign manufacturing for pharmaceuticals is causing widespread drug shortages. Learn how China and India supply most of the world's active ingredients-and why diversifying supply chains is critical for patient safety.
Evergreening lets pharmaceutical companies extend drug monopolies with minor changes, blocking cheaper generics and keeping prices high. Learn how it works and why it hurts patients.